ERBB2 and breast carcinoma: Based on molecular markers, breast cancer can be categorized into three primary subtypes, each exhibiting distinct risk profiles: estrogen or progesterone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+) and triple-negative (TN) breast cancer5,6.